Genes controlling macrophage activation appear to play a critical role in protective immunity against challenge Schistosoma mansoni infection in mice sensitized by primary infection or vaccination with irradiated cercariae. This proposal aims to determine in what way(s) the function of these genes controls expression of resistance, using techniques of cellular immunology and immunogenetics. The 3 major functions of macrophages in immune response will be compared in inbred strains of mice previously found to develop high levels of concomitant or vaccine-induced immunity (measured by recovery of challenge parasites) and in macrophage-deficient strains found to develop low levels of resistance. Macrophage accessory cell function will be assessed by the ability of cells to process and present antigens in an immunogenic form to lymphocytes in vitro and by development of delayed hypersensitivity and antibody responses in vivo. Effector cell function will be examined as the ability of macrophages activated as a result of specific anti-S. mansoni immune response, or their products, to damage schistosomes. The ability of specific antigen-responsive (lymphokine producing) T lymphocytes to transfer immunity will also be tested. Immunoregulatory function, by virtue of inhibitory products such as prostaglandins or by antigen presentation in a way that stimulates suppressor T cells, will be examined. In addition, since genes controlling macrophage activation are not yet identified and only functionally defined, and therefore may control resistance through mechanisms not directly involving macrophages, levels of other responses proposed to influence resistance (eg. egg-related pathology, granulocytosis) will be monitored. Initial analyses will allow detection of any abnormalities in low responder (non-resistant) mice, and thus reveal those responses that may be relevant to immunity. These reactivities will then be examined in immunized backcross (low responder x F1) animals. Positive reactivity will be correlated with the ability to resist challenge infection in individual mice; linkage analysis will allow final identification of responses crucial to resistance. This knowledge should facilitate design of a simpler vaccine protocol in which immune responses of proven protective value can be invoked by stimulation with non-living antigens.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Unknown (R22)
Project #
5R22AI021082-03
Application #
3444692
Study Section
Tropical Medicine and Parasitology Study Section (TMP)
Project Start
1983-09-01
Project End
1986-08-31
Budget Start
1985-09-01
Budget End
1986-08-31
Support Year
3
Fiscal Year
1985
Total Cost
Indirect Cost
Name
George Washington University
Department
Type
Schools of Medicine
DUNS #
City
Washington
State
DC
Country
United States
Zip Code
20052
Correa-Oliveira, R; James, S L; Sher, A (1988) Genetic complementation of defects in vaccine-induced immunity against Schistosoma mansoni in P- and A-strain inbred mice. Infect Immun 56:708-10
James, S L; Correa-Oliveira, R; Sher, A et al. (1987) Genetic association of defects in macrophage larvicidal activity and vaccine-induced resistance to Schistosoma mansoni in P strain mice. Infect Immun 55:1884-9
James, S L (1987) Schistosoma spp.: progress toward a defined vaccine. Exp Parasitol 63:247-52
Lewis, F A; Winestock, J; James, S L (1987) Macrophage activation as an immune correlate to protective immunity against schistosomiasis in mice immunized with an irradiated, cryopreserved live vaccine. Infect Immun 55:1339-45
James, S L (1986) Activated macrophages as effector cells of protective immunity to schistosomiasis. Immunol Res 5:139-48
Pearce, E J; James, S L (1986) Post lung-stage schistosomula of Schistosoma mansoni exhibit transient susceptibility to macrophage-mediated cytotoxicity in vitro that may relate to late phase killing in vivo. Parasite Immunol 8:513-27
James, S L; DeBlois, L A (1986) Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. II. Response of mouse strains with selective immune defects. J Immunol 136:3864-71
Correa-Oliveira, R; James, S L; McCall, D et al. (1986) Identification of a genetic locus, Rsm-1, controlling protective immunity against Schistosoma mansoni. J Immunol 137:2014-9
James, S L (1986) Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. III. Correlation of resistance with induction of activated larvacidal macrophages. J Immunol 136:3872-7
Pearce, E J; James, S L; Dalton, J et al. (1986) Immunochemical characterization and purification of Sm-97, a Schistosoma mansoni antigen monospecifically recognized by antibodies from mice protectively immunized with a nonliving vaccine. J Immunol 137:3593-600

Showing the most recent 10 out of 14 publications